TRAK vs. UPBD, ASTH, FLYW, CRTO, EVH, RDWR, STGW, CTOS, ETWO, and FVRR
Should you be buying ReposiTrak stock or one of its competitors? The main competitors of ReposiTrak include Upbound Group (UPBD), Astrana Health (ASTH), Flywire (FLYW), Criteo (CRTO), Evolent Health (EVH), Radware (RDWR), Stagwell (STGW), Custom Truck One Source (CTOS), E2open Parent (ETWO), and Fiverr International (FVRR). These companies are all part of the "business services" industry.
ReposiTrak vs. Its Competitors
Upbound Group (NASDAQ:UPBD) and ReposiTrak (NYSE:TRAK) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, risk and valuation.
Upbound Group pays an annual dividend of $1.56 per share and has a dividend yield of 5.8%. ReposiTrak pays an annual dividend of $0.07 per share and has a dividend yield of 0.3%. Upbound Group pays out 73.2% of its earnings in the form of a dividend. ReposiTrak pays out 20.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Upbound Group has raised its dividend for 5 consecutive years and ReposiTrak has raised its dividend for 2 consecutive years. Upbound Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Upbound Group has higher revenue and earnings than ReposiTrak. Upbound Group is trading at a lower price-to-earnings ratio than ReposiTrak, indicating that it is currently the more affordable of the two stocks.
ReposiTrak has a net margin of 30.13% compared to Upbound Group's net margin of 2.74%. Upbound Group's return on equity of 36.30% beat ReposiTrak's return on equity.
Upbound Group has a beta of 1.74, suggesting that its share price is 74% more volatile than the S&P 500. Comparatively, ReposiTrak has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500.
In the previous week, ReposiTrak had 2 more articles in the media than Upbound Group. MarketBeat recorded 6 mentions for ReposiTrak and 4 mentions for Upbound Group. Upbound Group's average media sentiment score of 1.01 beat ReposiTrak's score of 0.47 indicating that Upbound Group is being referred to more favorably in the media.
Upbound Group currently has a consensus target price of $34.50, suggesting a potential upside of 29.36%. Given Upbound Group's stronger consensus rating and higher possible upside, research analysts clearly believe Upbound Group is more favorable than ReposiTrak.
90.3% of Upbound Group shares are held by institutional investors. Comparatively, 27.4% of ReposiTrak shares are held by institutional investors. 2.6% of Upbound Group shares are held by company insiders. Comparatively, 44.0% of ReposiTrak shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Upbound Group beats ReposiTrak on 13 of the 20 factors compared between the two stocks.
Get ReposiTrak News Delivered to You Automatically
Sign up to receive the latest news and ratings for TRAK and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TRAK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
ReposiTrak Competitors List
Related Companies and Tools
This page (NYSE:TRAK) was last updated on 7/3/2025 by MarketBeat.com Staff